Torrent Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	21,630	19,113	16,564	12,452	7,772
Depreciation & Amortization	11,190	7,740	7,748	6,830	6,427
Other Amortization	-	209.3	204.6	190.3	192.8
Loss (Gain) From Sale of Assets	-180	-13.4	-883.6	-216.2	8.2
Asset Writedown & Restructuring Costs	-	-	129.7	45.6	2.3
Loss (Gain) From Sale of Investments	-320	-167.3	-179.9	-195.1	-101.4
Provision & Write-off of Bad Debts	60	17.7	70.8	22.7	9
Other Operating Activities	1,270	3,762	4,826	4,734	7,239
Change in Accounts Receivable	-2,540	171.7	783.2	-2,897	-1,091
Change in Inventory	350	-2,622	-494.3	2,557	2,189
Change in Accounts Payable	1,640	-2,777	4,136	-580.2	-3,924
Change in Other Net Operating Assets	-2,870	418.1	-243.6	738.3	-692.5
Operating Cash Flow	30,230	25,851	32,661	23,681	18,030
Operating Cash Flow Growth	16.94%	-20.85%	37.92%	31.34%	-10.09%
Capital Expenditures	-6,770	-6,119	-4,328	-5,739	-2,026
Sale of Property, Plant & Equipment	410	177.7	1,337	1,587	67.9
Cash Acquisitions	-123,150	-	-	-20,000	-
Investment in Securities	2,020	337.9	1,181	-129.8	-80.9
Other Investing Activities	360	202.6	131.2	129	72.4
Investing Cash Flow	-127,130	-5,401	-1,679	-24,153	-1,966
Short-Term Debt Issued	16,040	-	-	8,420	2,186
Long-Term Debt Issued	109,900	-	-	13,950	-
Total Debt Issued	125,940	-	-	22,370	2,186
Short-Term Debt Repaid	-	-3,963	-1,334	-	-
Long-Term Debt Repaid	-7,270	-5,564	-12,599	-9,936	-10,651
Total Debt Repaid	-7,270	-9,527	-13,933	-9,936	-10,651
Net Debt Issued (Repaid)	118,670	-9,527	-13,933	12,434	-8,464
Common Dividends Paid	-12,890	-10,830	-10,153	-5,132	-6,769
Other Financing Activities	-4,270	-2,622	-3,710	-3,030	-2,577
Financing Cash Flow	101,510	-22,980	-27,796	773.6	-17,811
Foreign Exchange Rate Adjustments	830	-87.3	80.7	211.2	5.3
Miscellaneous Cash Flow Adjustments	-	-	-	588.3	-
Net Cash Flow	5,440	-2,617	3,266	1,101	-1,742
Free Cash Flow	23,460	19,732	28,333	17,942	16,004
Free Cash Flow Growth	18.89%	-30.35%	57.92%	12.11%	-4.18%
Free Cash Flow Margin	16.78%	17.14%	26.41%	18.65%	18.81%
Free Cash Flow Per Share	69.33	58.30	83.72	53.01	47.29
Cash Interest Paid	4,270	2,622	3,710	3,030	2,577
Cash Income Tax Paid	8,090	6,028	4,981	3,981	4,210
Levered Free Cash Flow	22,778	12,787	22,213	14,783	10,209
Unlevered Free Cash Flow	25,184	14,358	24,417	16,860	11,790
Change in Working Capital	-3,420	-4,809	4,181	-182	-3,519

Source: S&P Global Market Intelligence. Standard template. Financial Sources.